News & Events

Please see below for all press releases and news articles relating to PolyProx Therapeutics, and details on events we will be attending:

Our News

02 March 2020 | PolyProx Raises an additional £1 million seed financing

PolyProx Therapeutics raises an additional £1 million seed financing from new investor, LifeArc, to validate polyproxin® drug leads in oncology.


30 April 2019 | PolyProx Raises Seed Financing

PolyProx Therapeutics raises £3.4m seed financing to validate novel class of drugs to treat cancer.


Upcoming events we are attending

17-19 March 2020 | Conference

1st Targeted Protein Degradation Summit, Europe | London, UK

Laura Itzhaki, our CSO, will be giving a talk on 'Harnessing the Cell’s Degradation Machineries, Nature’s Way to Manipulate Protein Stability".


Previously attended

11 December 2019 | Conference

Genesis 2019 | Westminster, London, UK

Laura Itzhaki, our CSO, will be joining Mike Anstey, a PolyProx investor from CIC, on a Parallel Leadership panel at the Genesis 2019 conference.


23-24 October 2019 | Conference

Targeted Protein Degradation (TPD) conference | Boston, USA

TPD 2019 is the most comprehensive and the definitive guide for large pharma, innovative biotech and leading academic researchers to capitalise on this emerging therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes.



27 September 2019 | Seminar

High-Throughput Production of Human Proteins for Structural and Functional Studies | Babraham Research Campus, Cambridge

Nicola Burgess-Brown is the Principal Investigator of the Biotechnology Group at the SGC in Oxford. Nicola’s team develops high-throughput screening processes from cloning to expression, purification and mass spectrometry analysis of human proteins for structural and functional studies. 


23 September 2019 | Conference

RAREsummit19 | Wellcome Genome CampusCambridge

Hear from, learn from and engage in cross-sector activities with a range of stakeholders who are leading the way in pioneering partnerships to accelerate change int the rare disease sector.



18-19 September 2019 | Conference

PROTACs and Targeted Protein Degradation Congress | Boston, USA

Cambridge Healthtech Institute’s conference on PROTACs and Targeted Protein Degradation will bring together a diverse group of chemists and biologists to discuss the prospects, as well as, the challenges underlying strategies for targeted protein degradation.



Contact us

If you are also attending an event and would like to meet a member of the team, please contact us